This is an old revision of this page, as edited by CheMoBot (talk | contribs) at 19:48, 1 September 2011 (Updating {{drugbox}} (no changed fields - updated 'ChemSpiderID_Ref', 'DrugBank_Ref', 'UNII_Ref', 'ChEMBL_Ref', 'ChEBI_Ref', 'KEGG_Ref', 'StdInChI_Ref', 'StdInChIKey_Ref', 'ChEBI_Ref') per Chem/Drugbox validation (report [[Misplaced Pages). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Revision as of 19:48, 1 September 2011 by CheMoBot (talk | contribs) (Updating {{drugbox}} (no changed fields - updated 'ChemSpiderID_Ref', 'DrugBank_Ref', 'UNII_Ref', 'ChEMBL_Ref', 'ChEBI_Ref', 'KEGG_Ref', 'StdInChI_Ref', 'StdInChIKey_Ref', 'ChEBI_Ref') per Chem/Drugbox validation (report [[Misplaced Pages)(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff) Pharmaceutical compound| Clinical data | |
|---|---|
| AHFS/Drugs.com | International Drug Names |
| ATC code | |
| Identifiers | |
| CAS Number | |
| (verify) | |
Parnaparin is an antithrombotic in the heparin group.
External links
- parnaparin at the U.S. National Library of Medicine Medical Subject Headings (MeSH)
- Maugeri N, Di Fabio G, Barbanti M, de Gaetano G, Donati MB, Cerletti C (2007). "Parnaparin, a low-molecular-weight heparin, prevents P-selectin-dependent formation of platelet-leukocyte aggregates in human whole blood". Thromb. Haemost. 97 (6): 965–73. PMID 17549299.
{{cite journal}}: CS1 maint: multiple names: authors list (link)
| Antithrombotics (thrombolytics, anticoagulants and antiplatelet drugs) (B01) | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Antiplatelet drugs |
| ||||||||||||||
| Anticoagulants |
| ||||||||||||||
| Thrombolytic drugs/ fibrinolytics | |||||||||||||||
| Non-medicinal | |||||||||||||||
| |||||||||||||||
 | This drug article relating to the blood and blood forming organs is a stub. You can help Misplaced Pages by expanding it. |